The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction.
Bennett TD, Moffitt RA, Hajagos JG, Amor B, Anand A, Bissell MM, Bradwell KR, Bremer C, Byrd JB, Denham A, DeWitt PE, Gabriel D, Garibaldi BT, Girvin AT, Guinney J, Hill EL, Hong SS, Jimenez H, Kavuluru R, Kostka K, Lehmann HP, Levitt E, Mallipattu SK, Manna A, McMurry JA, Morris M, Muschelli J, Neumann AJ, Palchuk MB, Pfaff ER, Qian Z, Qureshi N, Russell S, Spratt H, Walden A, Williams AE, Wooldridge JT, Yoo YJ, Zhang XT, Zhu RL, Austin CP, Saltz JH, Gersing KR, Haendel MA, Chute CG; N3C Consortium.
Bennett TD, et al.
medRxiv [Preprint]. 2021 Jan 23:2021.01.12.21249511. doi: 10.1101/2021.01.12.21249511.
medRxiv. 2021.
PMID: 33469592
Free PMC article.
Updated.
Preprint.
BACKGROUND: The majority of U.S. reports of COVID-19 clinical characteristics, disease course, and treatments are from single health systems or focused on one domain. Here we report the creation of the National COVID Cohort Collaborative (N3C), a centralized, harmonized, h …
BACKGROUND: The majority of U.S. reports of COVID-19 clinical characteristics, disease course, and treatments are from single health …